Patents by Inventor Déborah Tribouillard

Déborah Tribouillard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230310348
    Abstract: The present invention relates to the use of Alverine or one of its derivatives for treating diseases associated with mitochondrial dysfunction, especially with mitochondrial complex I deficiency.
    Type: Application
    Filed: July 26, 2021
    Publication date: October 5, 2023
    Inventors: Vincent PROCACCIO, Carole SELLEM, Agnes DELAHODDE, Aurelie RENAUD, Deborah TRIBOUILLARD-TANVIER, Stephane AZOULAY
  • Publication number: 20220241223
    Abstract: The present invention relates to the use of disulfiram or one of its derivatives for use in the treatment of a mitochondrial dysfunction or diseases, advantageously of a genetic mitochondrial disease.
    Type: Application
    Filed: June 19, 2020
    Publication date: August 4, 2022
    Inventors: Vincent PROCACCIO, Agnès RÖTIG, Agnès DELAHODDE, Déborah TRIBOUILLARD-TANVIER, Geneviève DUJARDIN, Marc BLONDEL
  • Publication number: 20110251428
    Abstract: The invention relates to chlorine Guanabenz derivatives for treating prion-based diseases. More specifically, it relates to the use of the molecule of formula (I) wherein R?H or Cl and the phenyl group is at least substituted twice, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for treating prion-based diseases.
    Type: Application
    Filed: October 3, 2007
    Publication date: October 13, 2011
    Inventors: Marc Blondel, Stéphane Bach, Didier Vilette, Vincent Beringue, Déborah Tribouillard